Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Rayner

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
The Medical Journal of Australia|August 14, 2003
Dosing information for paediatric patients: are they really "therapeutic orphans"?Elaine Tan, Noel E Cranswick, Craig R Rayner, et al.
The Annals of Pharmacotherapy|June 28, 2002
A critical evaluation of the therapeutic range of indinavirCraig R Rayner, Kirsten J Galbraith, Jennifer L Marriott, et al.
Clinical and Translational Science|May 23, 2020
Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19Dan Hartman, Steven Kern, Fran Brown, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patientsStephanie J Wallace, Jian Li, Craig R Rayner, et al.
Infectious Diseases and Therapy|August 20, 2021
Correction to: Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Infectious Diseases and Therapy|October 14, 2020
Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Journal of Clinical Pharmacology|June 6, 2008
Population pharmacokinetics of oseltamivir when coadministered with probenecidCraig R Rayner, Pascal Chanu, Ronald Gieschke, et al.
The Annals of Pharmacotherapy|August 31, 2006
Pharmacokinetics of oseltamivir in young and very elderly subjectsMasaichi Abe, James Smith, Akinori Urae, et al.
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programmeCraig R Rayner, Alan Forrest, Alison K Meagher, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetics of linezolid in patients treated in a compassionate-use programAlison K Meagher, Alan Forrest, Craig R Rayner, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
The Medical Journal of Australia|August 14, 2003
Dosing information for paediatric patients: are they really "therapeutic orphans"?Elaine Tan, Noel E Cranswick, Craig R Rayner, et al.
The Annals of Pharmacotherapy|June 28, 2002
A critical evaluation of the therapeutic range of indinavirCraig R Rayner, Kirsten J Galbraith, Jennifer L Marriott, et al.
Clinical and Translational Science|May 23, 2020
Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19Dan Hartman, Steven Kern, Fran Brown, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patientsStephanie J Wallace, Jian Li, Craig R Rayner, et al.
Infectious Diseases and Therapy|August 20, 2021
Correction to: Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Infectious Diseases and Therapy|October 14, 2020
Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Journal of Clinical Pharmacology|June 6, 2008
Population pharmacokinetics of oseltamivir when coadministered with probenecidCraig R Rayner, Pascal Chanu, Ronald Gieschke, et al.
The Annals of Pharmacotherapy|August 31, 2006
Pharmacokinetics of oseltamivir in young and very elderly subjectsMasaichi Abe, James Smith, Akinori Urae, et al.
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programmeCraig R Rayner, Alan Forrest, Alison K Meagher, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetics of linezolid in patients treated in a compassionate-use programAlison K Meagher, Alan Forrest, Craig R Rayner, et al.
Pageof 7